The book-built IPO of Rs 1,952.03 crores is Emcure Pharma IPO . The offering for sale of 1.14 crore shares, valued at Rs 1,152.03 crores, and the new issuance of 0.79 crore shares, totaling Rs 800.00 crores, make up the issue.
The subscription period for the Emcure Pharma IPO begins on July 3, 2024, and ends on July 5, 2024. On Monday, July 8, 2024, the allotment for the Emcure Pharma IPO is anticipated to be completed. The Emcure Pharma initial public offering (IPO) is scheduled to go live on the BSE and NSE on Wednesday, July 10, 2024.
The pricing range for the Emcure Pharma IPO is ₹960 to ₹1008 per share. Applications must have a minimum lot size of 14 shares. Retail investors are required to invest a minimum of ₹14,112. For both sNII and bNII, the minimum lot size investment is 15 lots (210 shares), or ₹211,680, and 71 lots (994 shares), or ₹1,001,952.
The registrar for the Emcure Pharma IPO is Link Intime India Private Ltd, and the book running lead managers of the offering are the following firms: Kotak Mahindra Capital Company Limited, Axis Capital Limited, J.P. Morgan India Private Ltd., and Jefferies India Private Ltd:
For more information, see the Emcure Pharma IPO RHP:
Emcure pharma IPO details-
| IPO Date | July 3, 2024 to July 5, 2024 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price Band | ₹960 to ₹1008 per share |
| Lot Size | 14 Shares |
| Total Issue Size | 19,365,346 shares (aggregating up to ₹1,952.03 Cr) |
| Fresh Issue | 7,936,507 shares (aggregating up to ₹800.00 Cr) |
| Offer for Sale | 11,428,839 shares of ₹10 (aggregating up to ₹1,152.03 Cr) |
Timetable for Emcure Pharma’s IPO (Estimated Schedule)
| IPO Open Date | Wednesday, July 3, 2024 |
| IPO Close Date | Friday, July 5, 2024 |
| Basis of Allotment | Monday, July 8, 2024 |
| Initiation of Refunds | Tuesday, July 9, 2024 |
| Credit of Shares to Demat | Tuesday, July 9, 2024 |
| Listing Date | Wednesday, July 10, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on July 5, 2024 |
Lot Size for Emcure Pharma’s IPO
Offerings can be placed for multiples of 14 shares, with a minimum bid of 14. The lowest and highest share and amount investments made by HNIs and retail investors are shown in the table below.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 14 | ₹14,112 |
| Retail (Max) | 14 | 196 | ₹197,568 |
| S-HNI (Min) | 15 | 210 | ₹211,680 |
| S-HNI (Max) | 70 | 980 | ₹987,840 |
| B-HNI (Min) | 71 | 994 | ₹1,001,952 Lot size calculator |
Emcure Pharma Reservation for IPO
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| NII (HNI) Shares Offered | Not more than 15% of the Net Issue |
Information about Emcure Pharmaceuticals Ltd.
Established in 1981, Emcure Pharmaceuticals Limited is an Indian pharmaceutical enterprise that engages in the development, production, and international distribution of an extensive array of pharmaceutical products spanning multiple major therapeutic domains.
According to MAT September 2023, the company’s domestic sales ranking among pharmaceutical companies in India was 13th, while its market share in its covered markets during the same time was 4th. Furthermore, as of September 2023, it is the top pharmaceutical company in the fields of HIV antiviral therapy and gynecology.
Sales in India accounted for 50.84% and 53.16% of the company’s overall revenue in the six months that ended on September 30, 2023, and the Financial Year 2023, respectively. Between September 2019 and September 2023, the company’s domestic sales expanded at a compound annual growth rate (CAGR) of 10.80%, outpacing the pharmaceutical market in India.
Financial Data for Emcure Pharmaceuticals Limited (consolidated and restated)
Between March 31, 2024, and March 31, 2023, Emcure Pharmaceuticals Limited’s profit after tax (PAT) decreased by -6.1% while its revenue climbed by 11.33%.
| Period Ended | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 7,806.16 | 6,672.53 | 6,063.47 |
| Revenue | 6,715.24 | 6,031.72 | 5,918.86 |
| Profit After Tax | 527.58 | 561.85 | 702.56 |
| Net Worth | 2,952.28 | 2,501.13 | 1,987.55 |
| Reserves and Surplus | 2,722.40 | 2,293.77 | 1,791.03 |
| Total Borrowing | 2,091.94 | 2,202.42 | 2,102.19 |
FAQ’s
When will the IPO for Emcure Pharma open?
On July 3, 2024, the IPO for Emcure Pharma will begin, and it will end on July 5, 2024.
What is the Emcure Pharma IPO lot size?
The minimum amount needed for the Emcure Pharma IPO is ₹14,112. The lot size for the IPO is 14 shares.
When will shares in Emcure Pharma go public?
On Monday, July 8, 2024, the Basis of Allotment for the Emcure Pharma IPO will be finalized. By Tuesday, July 9, 2024, the assigned shares will be credited to your demat account. Verify the allotment status for the Emcure Pharma IPO.
Techarp Nice post. I learn something totally new and challenging on websites